Back to RPRX

Mraz, Amerine & Associates, Inc. → RPRX

Mraz, Amerine & Associates, Inc. RPRX Position History

Royalty Pharma plc

Quarters held
8
Latest value
$266K
Q3 2026
Peak value
$6.3M
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$4.1M
Q4 2025$4.6M
Q1 2026$6.3M
Q1 2026$218K
Q2 2026$5.8M
Q2 2026$255K
Q3 2026$6.3M
Q3 2026$266K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$266K4.5K——
Q3 2026$6.3M129.0K——
Q2 2026$255K4.5K——
Q2 2026$5.8M124.8K——
Q1 2026$218K4.5K——
Q1 2026$6.3M122.8K——
Q4 2025$4.6M120.3K——
Q3 2025$4.1M118.4K——

Other funds holding RPRX

Other Mraz, Amerine & Associates, Inc. positions

BRK-A

BERKSHIRE HATHAWAY INC DEL

$82.1M
BRK-A

BERKSHIRE HATHAWAY INC DEL

$81.1M
BRK-A

BERKSHIRE HATHAWAY INC DEL

$78.3M
BRK-A

BERKSHIRE HATHAWAY INC DEL

$76.7M
BRK-A

BERKSHIRE HATHAWAY INC DEL

$76M
FRFFF

FAIRFAX FINL HLDGS LTD SUB VTG

$55.5M
FRFFF

FAIRFAX FINL HLDGS LTD SUB VTG

$50.7M
FRFFF

FAIRFAX FINL HLDGS LTD SUB VTG

$49.6M